No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina / NY / Florida       

Sera Prognostics Appoints Woodrow Myers, MD, MBA As Advisor Of Public And Political Affairs

Dr. Myers to support Sera's commitment to reduce healthcare disparities among underserved communities

What To Know

  • Myers will work on a multi-disciplinary effort to execute a national and state-specific political and public affairs strategy focused on Health Equity and Disparities related to pregnancy and parturition, further emphasizing the Company’s efforts to help address the healthcare disparities that disproportionately affect underserved communities.
  • In higher education, he served on the Board of Trustees of Stanford University, the Board of Overseers of Harvard University, and the Board of Trustees of the Charles R.

Sera Prognostics Inc., The Pregnancy Company™ (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that Woodrow Myers, M.D., M.B.A., joins Sera as an advisor focusing on public and political affairs.

Dr. Myers will work on a multi-disciplinary effort to execute a national and state-specific political and public affairs strategy focused on Health Equity and Disparities related to pregnancy and parturition, further emphasizing the Company’s efforts to help address the healthcare disparities that disproportionately affect underserved communities.

“We are honored to have Dr. Myers join the Sera Prognostics team, bringing his extensive experience and leadership in addressing health equity and disparities,” said Gregory C. Critchfield, M.D., M.S., Chairman, and CEO of Sera Prognostics. “Dr. Myers has coupled his passion for the highest standards of patient care and management with leadership roles in several of our largest and most innovative healthcare enterprises.”

Dr. Myers is a nationally recognized leader in developing medical quality initiatives and advanced healthcare management programs. He serves as National Health Policy Advisor for the Wellness and Equity Alliance. Dr. Myers is on the boards of Personalis, Inc., Freespira Inc., and the Public Health Policy Committee of eHealth Inc. He has also served as Chief Medical Officer and Chief Healthcare Strategist for Blue Cross Blue Shield of Arizona, Chief Executive Officer for Valitàs Health Services (Corizon Health), and consultant to the California Endowment. In addition, Dr. Myers has served on multiple public, private, and nonprofit boards, including Express Scripts, Genomic Health, LipoScience, and SynGen. In higher education, he served on the Board of Trustees of Stanford University, the Board of Overseers of Harvard University, and the Board of Trustees of the Charles R. Drew University of Medicine and Science.

“I am excited to work with the team at Sera Prognostics who share my commitment to improving the quality, availability, and efficiency of healthcare around the globe,” said Dr. Myers. “I am looking forward to utilizing my passion for innovation and technology upgrades that will improve healthcare delivery and human longevity.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More

Advertise wiith Medical Device News Magazine

By using this website you agree to accept Medical Device News Magazine Privacy Policy